Reviva Pharmaceuticals Holdings Inc. (RVPH)

Official site

HEALTHCARE • BIOTECHNOLOGY • PINK

$0.50

+0.01 (+1.08%)

Market Cap: $6.13M

Last updated: Oct 13, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

58%(14/24)

Avg Surprise

-319.31%

Streak

1 Q

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.18

Range$-0.18 - $-0.18

1 analysts

EPS Revisions

30d

EPS Estimate DriftChange to current

90d ago$-0.23+21.7%

60d ago$-0.36+50.0%

30d ago$-0.36+50.0%

7d ago$-0.36+50.0%

Current$-0.18

Revenue Consensus

Range$0 - $0

1 analysts

Period ending Dec 31, 2026

EPS Consensus$0.03

Range$0.03 - $0.03

1 analysts

Revenue Consensus

Range$0 - $0

1 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$0.03	$0.03 - $0.03	-	-	1	-	-
Sep 30, 2026Sep 26EST	-	$-0.18	$-0.18 - $-0.18	-	-	1	1 0 30d	-
Jun 30, 2026Jun 26 Reported Aug 12, 2026Reported Aug 12	$-0.19	N/A	-	+53.66%	Beat	1	0 1 30d	+92.1%
Mar 31, 2026Mar 26 Reported May 14, 2026Reported May 14	$-0.46	$-0.29	$-0.29 - $-0.29	-58.62%	Miss	2	2 0 30d	+82.3%
Dec 31, 2025Dec 25 Reported Mar 30, 2026Reported Mar 30	$-5.19	$-0.07	$-0.80 - $0.40	-7179.10%	Miss	6	1 0 30d	-476.7%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-1.20	$-1.94	$-1.97 - $-1.88	+38.14%	Beat	7	1 0 30d	+76.0%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-2.40	$-2.20	$-2.23 - $-2.17	-9.09%	Miss	4	2 0 30d	+53.8%
Mar 31, 2025Mar 25 Reported May 15, 2025Reported May 15	$-2.60	$-3.65	$-3.67 - $-3.64	+28.77%	Beat	4	3 0 30d	+48.0%
Dec 31, 2024Dec 24 Reported Mar 31, 2025Reported Mar 31	$-0.90	$-0.23	$-0.25 - $-0.19	-300.00%	Miss	5	No revisions (30d)	-157.1%
Sep 30, 2024Sep 24 Reported Nov 14, 2024Reported Nov 14	$-5.00	$-5.00	$-5.06 - $-4.95	+0.00%	Beat	4	2 0 30d	+43.2%
Jun 30, 2024Jun 24 Reported Aug 14, 2024Reported Aug 14	$-5.20	$-6.20	$-6.22 - $-6.18	+16.13%	Beat	4	No revisions (30d)	+52.7%
Mar 31, 2024Mar 24 Reported Apr 15, 2024Reported Apr 15	$-5.00	$-7.53	$-7.61 - $-7.43	+33.60%	Beat	3	1 0 30d	+16.7%
Dec 31, 2023Dec 23 Reported Mar 19, 2024Reported Mar 19	$-0.35	$-0.35	$-0.38 - $-0.29	+0.00%	Beat	4	No revisions (30d)	+7.9%
Sep 30, 2023Sep 23 Reported Nov 14, 2023Reported Nov 14	$-8.80	$-7.75	$-7.91 - $-7.63	-13.55%	Miss	5	No revisions (30d)	-144.4%
Jun 30, 2023Jun 23 Reported Aug 14, 2023Reported Aug 14	$-11.00	$-5.00	$-5.06 - $-4.94	-120.00%	Miss	5	No revisions (30d)	-89.7%
Mar 31, 2023Mar 23 Reported May 15, 2023Reported May 15	$-6.00	$-5.80	$-5.84 - $-5.77	-3.45%	Miss	2	No revisions (30d)	+25.0%
Dec 31, 2022Dec 22 Reported Mar 30, 2023Reported Mar 30	$-0.38	$-0.22	$-0.27 - $-0.19	-72.73%	Miss	4	No revisions (30d)	-72.7%
Sep 30, 2022Sep 22 Reported Nov 14, 2022Reported Nov 14	$-3.60	$-5.20	$-5.21 - $-5.17	+30.77%	Beat	3	No revisions (30d)	-50.0%
Jun 30, 2022Jun 22 Reported Aug 15, 2022Reported Aug 15	$-5.80	$-7.00	$-7.00 - $-7.00	+17.14%	Beat	0	No revisions (30d)	-141.7%
Mar 31, 2022Mar 22 Reported May 16, 2022Reported May 16	$-8.00	$-5.00	$-5.00 - $-5.00	-60.00%	Miss	1	No revisions (30d)	-7900.0%
Dec 31, 2021Dec 21 Reported Mar 15, 2022Reported Mar 15	$-0.22	$-0.25	$-0.27 - $-0.22	+12.00%	Beat	3	1 0 30d	+93.3%
Sep 30, 2021Sep 21 Reported Nov 15, 2021Reported Nov 15	$-2.40	$-4.60	$-4.62 - $-4.59	+47.83%	Beat	2	No revisions (30d)	-5900.0%
Jun 30, 2021Jun 21 Reported Aug 16, 2021Reported Aug 16	$-2.40	$-4.80	-	+50.00%	Beat	-	-	-3900.0%
Mar 31, 2021Mar 21 Reported May 17, 2021Reported May 17	$-0.10	$-0.10	-	+0.00%	Beat	-	-	-100.0%
Dec 31, 2020Dec 20 Reported Mar 22, 2021Reported Mar 22	$-3.30	$-1.20	$-1.20 - $-1.20	-175.00%	Miss	0	No revisions (30d)	-6700.0%
Sep 30, 2020Sep 20 Reported Dec 2, 2020Reported Dec 2	$-0.04	$-0.04	$-0.04 - $-0.04	+0.00%	Beat	0	No revisions (30d)	-136.4%
Jun 30, 2020Jun 20 Reported Jul 7, 2020Reported Jul 7	$-0.06	N/A	-	N/A	Beat	-	-	-146.2%
Mar 31, 2020Mar 20 Reported May 1, 2020Reported May 1	$-0.05	N/A	-	N/A	Beat	-	-	-101.9%
Dec 31, 2019Dec 19 Reported Jan 10, 2020Reported Jan 10	$0.05	N/A	-	N/A	Beat	-	-	-93.3%
Sep 30, 2019Sep 19 Reported Oct 8, 2019Reported Oct 8	$0.11	N/A	-	N/A	Beat	-	-	-94.6%
Jun 30, 2019Jun 19 Reported Jul 3, 2019Reported Jul 3	$0.13	N/A	-	N/A	Beat	-	-	-
Mar 31, 2019Mar 19 Reported May 22, 2019Reported May 22	$2.60	N/A	-	N/A	Beat	-	-	-
Dec 31, 2018Dec 18 Reported Jan 9, 2019Reported Jan 9	$0.74	N/A	-	N/A	Beat	-	-	-
Sep 30, 2018Sep 18 Reported Oct 11, 2018Reported Oct 11	$2.03	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.07	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-176.60%	ROIC	-87.76%
Financial Health
Debt/Equity	0.01x	Interest Coverage	-2049.61x
Current Ratio	3.56x	Quick Ratio	3.56x
Trading Statistics
Beta	0.48	Avg Volume	22.18K
52-Week High	$15.40	52-Week Low	$0.26

Technical Indicators Dashboard

Moving Averages

SMA 10$0.50

SMA 20$0.50

SMA 50$0.49

SMA 200$1.90

EMA 10$0.50

EMA 20$0.50

EMA 50$0.52

EMA 200$2.55

MACD

Line: -0.00Signal: -0.00Hist: 0.00

ADX

ADX: 15.1+DI: 10.6-DI: 13.0

Aroon & PSAR

Aroon Up4.0

Aroon Down96.0

PSAR$0.54

Bollinger Bands

Upper Band$0.53

Lower Band$0.47

%B Position1219%(Upper)

Band Width0.50

RSI (14-Day)

Neutral

49.3

Momentum Oscillators

Stoch %K49.3

Stoch %D44.4

Williams %R-44.9

ROC (10d)3.8%

Momentum0.02

CCI (20d)-64.8

MFI (14d)47.3

Volatility Measures

ATR (14d)$0.05(9.4%)

StdDev (20d)0.02

Hist Vol67.9%(High)

Volume Flow

VWAP$0.49

OBV-22.6M

AD Line375.1B

CMF (20d)-0.234

Volume Metrics

Avg Vol (20d)22.0K

Vol Ratio0.7x

VWMA (20d)$0.49

Pivot Points

R3$0.57

R2$0.54

R1$0.51

Pivot Point$0.48

S1$0.45

S2$0.42

S3$0.40

Advanced Oscillators

TSI-0.88

Ultimate Osc50.4

KST-8.42

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Cost of Revenue	$0	$0	N/A	$0	$0	$0	N/A	$0	$0	$0	N/A	$0
Gross Profit	$0	$0	N/A	$0	$0	$0	N/A	$0	$0	$0	N/A	$0

Operating Expenses	$2.62M	$3.27M	$3.56M	$4.03M	$6.07M	$6.54M	$6.28M	$8.46M	$8.13M	$7.92M	$9.62M	$11.56M
R&D	$1.39M	$1.44M	$1.74M	$2.13M	$3.72M	$4.11M	$4.68M	$6.86M	$5.58M	$5.78M	$8.11M	$9.57M
SG&A	$1.22M	$1.84M	$1.82M	$1.90M	$2.35M	$2.42M	$1.60M	$1.60M	$2.55M	$2.14M	$1.51M	$1.99M
Operating Income	$-2,617,543	$-3,271,952	$-3,559,041	$-4,029,841	$-6,072,982	$-6,538,167	$-6,284,606	$-8,462,534	$-8,129,643	$-7,922,106	$-9,619,346	$-11,563,954

Interest Income	$176,319	$89,354	$143,309	$59,103	$22,847	$86,111	$47,413	$53,248	$87,610	$173,098	$56,559	$91,763
Interest Expense	$2,935	$6,653	$-5,620	$2,605	$4,797	$11,620	$4,711	$5,146	$5,153	$3,487	$7,410	$5,901
Income Before Tax	$-2,445,199	$-3,192,641	$-3,364,797	$-4,007,933	$-6,045,656	$-6,427,627	$-6,254,744	$-8,365,798	$-7,852,534	$-7,426,212	$-9,359,846	$-11,333,819
Income Tax Expense	$2,632	$3,346	$2,882	$2,840	$7,954	$5,213	$4,733	$0	$7,385	$7,396	$-4,582	$12,117

Net Income	$-2,447,831	$-3,195,987	$-3,367,679	$-4,010,773	$-6,053,610	$-6,432,840	$-6,259,477	$-8,365,798	$-7,859,919	$-7,433,608	$-9,355,264	$-11,345,936

EBITDA	$-2,618,583	$-3,275,342	$-3,513,726	$-4,064,431	$-6,063,706	$-6,502,118	$-6,297,446	$-8,413,900	$-7,934,991	$-7,595,823	$-9,408,995	$-11,419,681
EBIT	$-2,618,583	$-3,275,342	$-3,513,726	$-4,064,431	$-6,063,706	$-6,502,118	$-6,297,446	$-8,413,900	$-7,934,991	$-7,595,823	$-9,408,995	$-11,419,681

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about RVPH

News

Millennium entities (RVPH) disclose 1.07M-share, 8.2% Reviva Pharmaceuticals stake

Millennium entities, including Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, have disclosed a beneficial ownership of 1,072,690 shares...

Stock Titan•Aug 3, 2026 5:39 PM ET8/3/26•Neutral

UBS Group (RVPH) exits Reviva Pharmaceuticals stake in updated report

UBS Group AG, along with its subsidiaries, has reported that it no longer beneficially owns any shares of Reviva Pharmaceuticals Holdings, Inc. common stock as of June 30...

Stock Titan•Aug 1, 2026 12:11 AM ET8/1/26•Neutral

REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. Market Sentiment

This article provides an overview of market sentiment for Reviva Pharmaceuticals Holdings, Inc. (RVPH), including analyst consensus, short interest...

Benzinga España•Jul 27, 2026 9:50 AM ET7/27/26•Somewhat-Bullish

Operating margin % of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH

The article provides the operating margin percentage for Reviva Pharmaceuticals Holdings, Inc. (OTC: RVPH), as seen on TradingView. It highlights that the market is currently closed with no trades. The content primarily...

TradingView•Jul 18, 2026 5:39 PM ET7/18/26•Neutral

RVPH Valuation and Fair Value

P/E: -0.1x
P/B: 0.4x

See GNG's fair value

RVPH Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROIC: -87.8%
ROE: -176.6%

RVPH Competitors

Company	Ticker
Traws Pharma Inc	TRAW
Zhongchao Inc	ZCMD
Enveric Biosciences Inc	ENVB
Healthcare Triangle Inc	HCTI
Co-Diagnostics, Inc. Common Stock	CODX
WORK Medical Technology Group LTD Ordinary Shares	WOK
Neurosense Therapeutics Ltd	NRSN
Creative Medical Technology Holdings Inc	CELZ

Sector: Healthcare

RVPH Bull Case vs Bear Case

Bear case

RVPH beat EPS estimates in 37.5% of its last 8 reported quarters.

RVPH Earnings: Beat Rate and Next Report

Beat rate: 3 of 8 quarters (37.5%)
Average surprise: -928.3%
EPS estimate (fiscal period ending Sep 30, 2026): $-0.18
Estimate revisions (30 days, fiscal period ending Sep 30, 2026): 1 up, 0 down

Frequently Asked Questions About RVPH

Does RVPH pay dividends?

Reviva Pharmaceuticals Holdings Inc. (RVPH) does not currently pay a regular dividend.

What is RVPH's market cap?

Reviva Pharmaceuticals Holdings Inc. (RVPH) has a market capitalization of $6.13M with a current stock price of $0.50.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In

Earnings

Performance (10Y)

Upcoming Estimates

Key Metrics

Technical Indicators Dashboard

Moving Averages

MACD

ADX

Aroon & PSAR

Bollinger Bands

RSI (14-Day)

Momentum Oscillators

Volatility Measures

Volume Flow

Volume Metrics

Pivot Points

Advanced Oscillators

Financial Data

Related GNG Research

News

Millennium entities (RVPH) disclose 1.07M-share, 8.2% Reviva Pharmaceuticals stake

UBS Group (RVPH) exits Reviva Pharmaceuticals stake in updated report

REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. Market Sentiment

Operating margin % of Reviva Pharmaceuticals Holdings, Inc. – OTC:RVPH

RVPH Valuation and Fair Value

RVPH Profitability: Margins, ROIC and FCF

RVPH Competitors

RVPH Bull Case vs Bear Case

Bear case

RVPH Earnings: Beat Rate and Next Report

Frequently Asked Questions About RVPH

Related stocks

Get full access to GNG Research